Multi-Million Dollar Grant Awarded for Organ Transplantation Research

Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million dollar grant from the NIH to advance research in organ transplantation and antibody mediated rejection.
Guidance for Second Medicare Drug Price Negotiation Released

The U.S. Department of Health and Human Services, through the Centers for Medicare and Medicaid Services, has released final guidance outlining the process for the second cycle of negotiations under the Medicare Drug Price Negotiation Program.
CMS Issues Final Rule on 2025 Home Health Prospective Payment Systems

The Centers for Medicare and Medicaid Services issued a final rule on its 2025 home health prospective payment system, which updates Medicare payment policies and rates for home health agencies.
First Nasal Self-Administered Flu Vaccine Approved by FDA

FluMist, the first influenza nasal spray vaccine that can be self-administered, has been approved by the U.S. Food and Drug Administration (FDA).
HHS Proposes Rule to Advance Health Equity

A rule has been proposed by the U.S. Department of Health and Human Services to advance health equity and support whole-person care.
New Type of Blood Test Can Identify Kids at Risk of Diabetes

Scientists at Kings College London have discovered a novel link between lipids and disorders affecting children’s metabolism that may provide an early warning system for obesity-related problems such as type 2 diabetes and liver and heart disease. The researchers say this could assist medical professionals in identifying early disease indicators in children more quickly and […]
Study Finds Repeat Dosing of IVIG and PLEX Common in GBS, Resulting in Harm to Nonresponders

According to randomized controlled trials, repeat intravenous immune globulin (IVIG) dosing and plasma exchange (PLEX) followed by IVIG (combination therapy) have no additional therapeutic benefit in Guillain-Barré syndrome (GBS) nonresponders. Furthermore, the delineation between GBS and acute onset chronic inflammatory demyelinating polyneuropathy (A-CIDP) can be particularly challenging and carries therapeutic implications. In the retrospective study […]
Study Finds Flu Vaccine Over 50% Effective Against Severe Disease in Children

According to a recent study published in JAMA Network Open, the estimated effectiveness of at least one dose of the influenza vaccine against emergency department visits or hospitalization was over 50 percent across disease severity levels among nearly 16,000 U.S. children during five respiratory illness seasons.
FDA Approves Celltrion’s Steqeyma to Treat Autoimmune Diseases

Celltrion has received U.S. Food and Drug Administration approval for its autoimmune disease treatment drug Steqeyma, a biosimilar of Johnson & Johnson’s Stelara (ustekinumab).
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma

The U.S. Food and Drug Administration (FDA) has granted fast track designation for its lead clinical-stage program, IMM-1-104, as a treatment for patients with unresectable or metastatic NRAS-mutant melanoma who have progressed on or are intolerant to PD-1/PD-L1-based immune checkpoint inhibitors.